Interleukin 18 and transforming growth factor β1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 549-552

  Myśliwiec, Janusz ^a   Krȩtowski, Adam ^a   Stȩpień, Agnieszka ^a   Mirończuk, Katarzyna ^a   Kinalska, Ida ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Corticosteroids; Graves' ophthalmopathy; IL 18; TGF 1

Indexed keywords

ANTIBODY; INTERLEUKIN 18; MEPREDNISONE; PREDNISONE; THYROID RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0037387302     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00045-6     Document Type: Article

References (15)

1. Natt N., Bahn R.S. Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity. 26:1997;129-133.
2. Heufelder A.E., Bahn R.S. Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur. J. Clin. Invest. 23:1993;10-17.
3. Myśliwiec J., Krȩtowski A., Topolska J., Siewko K., Jakubczyk D., Szelachowska M.et al. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids. Horm. Metab. Res. 33:2001;739-743.
4. McInnes I.B., Gracie J.A., Liew F.Y. Interleukin-18: a novel cytokine in inflammatory rheumatic disease. Arthritis Rheum. 44:2001;1481-1483.
5. Prud'homme G.J., Piccirillo C.A. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J. Autoimmun. 14:2000;23-42.
6. Ahmad R., Sindhu S.T., Toma E., Morisset R., Ahmad A. Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J. Virol. 76:2002;12448-12456.
7. McInnes I.B., Gracie J.A., Leung B.P., Wei X.Q., Liew F.Y. Interleukin-18: a pleiotropic participant in chronic inflammation. Immunol. Today. 21:2000;312-315.
8. Miyauchi S., Matsuura B., Onji M. Increased levels of serum interleukin-18 in Graves' disease. Thyroid. 10:2000;815-819.
9. Shibatomi K., Ida H., Yamasaki S., Nakashima T., Origuchi T., Kawakami A.et al. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Arthritis Rheum. 44:2001;884-892.
10. Wei X.Q., Leung B.P., Arthur M.H., McInnes I.B., Liew F.Y. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J. Immunol. 166:2001;517-521.
11. Plater-Zyberk C., Joosten L.A.B., Helsen M.M.A., Sattonnet-Roche P., Siegfried C., Alouani S.et al. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108:2001;1825-1832.
12. Barnes P.J. Antiinflammatory actions of corticosteroids: molecular mechanisms. Clin. Sci. 84:1998;557-572.
13. Seddon B., Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes. J. Exp. Med. 189:1999;279-288.
14. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:2001;423-474.
15. McCartney-Francis N.L., Frazier-Jessen M., Wahl S.M. TGF-beta: a balancing act. Int. Rev. Immunol. 16:1998;553-801.